Silence Therapeutics, PLC (LON: SLN) a leader in the discovery, development and delivery of novel RNA therapeutics for the treatment of serious diseases, is pleased to announce the appointment of...
Read MoreANGLE plc (AIM:AGL), a world-leading liquid biopsy company, is pleased to announce that top US cancer centre, the University of Texas MD Anderson Cancer Center has developed a new technique...
Read MoreSkinBioTherapeutics plc (AIM: SBTX), a life sciences company focused on skin health, announces the appointment of Stuart John Ashman to the Board as an Executive Director with effect from 18...
Read MoreVenture Life (AIM: VLG), a leader in developing, manufacturing and commercialising products for the international self-care market, announces its audited results for the year ended 31 December 2018....
Read MoreGalantas Gold Corporation is pleased to announce its audited annual financial results for the year ended December 31, 2018....
Read MoreD4t4 Solutions Plc (AIM: D4t4), specialists in data solutions, is pleased to provide the following trading update, ahead of the publication of the Group's final results for the financial year...
Read MoreRWS Holdings plc (RWS), one of the world's leading language, intellectual property support services and localization providers, today provides an update on trading for the half year ended 31 March...
Read MoreIofina, specialists in the exploration and production of iodine and manufacturers of other halogen-based derivatives at its specialty chemical company, today provides an update to the market regarding its activities...
Read MoreSerica Energy plc (AIM: SQZ) today announces its financial results for the year ended 31 December 2018....
Read MoreAmryt, a revenue-generating orphan drug company focused on acquiring, developing and commercialising products that help improve the lives of patients where there is a high unmet medical need, today announces its...
Read More